Go beyond dashboards. Use platform APIs to access deeper data, connect insights, and automate workflows that reveal new ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

KNOXVILLE, Tenn. — WBIR requested data from the Tennessee Department of Education that shows students who received Education Freedom Scholarships, or vouchers, were mostly from major cities and ...

The Atlanta Hawks regular season is eight days away from beginning and as one of the most talked about teams of the offseason, there are a lot of expectations surrounding the Hawks. While the ...

Welcome to Play Smart, a regular GOLF.com game-improvement column that will help you become a smarter, better golfer. To generate your maximum power, you’ve got to know how to properly shift your ...

From California to Colorado, one universal experience defines growing up in the American West. It’s not the wide-open skies. Or the deer and the antelope. It’s not even the lack of humidity, blissful ...

Merger creates $600-million-revenue data infrastructure company Fivetran CEO Fraser to lead combined company Deal highlights AI-driven data infrastructure demand Oct 13 (Reuters) - Data startups ...

Christophe Waggoner hosts a yearly event for kids — plus adults and dogs — to pick out Halloween costumes he gathers and mends. Christophe Waggoner has what he calls a “shopping problem.” Not for ...

X's head of product shared that the site is experimenting with show new user data in order to restore trust on the platform. Credit: NICOLAS TUCAT/AFP via Getty Images Elon Musk's X dropped its legacy ...

More than 2.8 million Brits have signed a petition as of Wednesday, calling on the U.K. government to reverse its mandatory Digital ID system over concerns it will lead to "mass surveillance and ...

Moderna has shared some of the phase 1/2 data that persuaded it to expand and prioritize development of a cancer candidate, reporting responses in melanoma patients failed by checkpoint inhibitors.